Israel Bio-pharma Research Market [Product (Consumables-Assay, Kits and Reagent, Cell Line, Instrument {Separation, Imaging}, Software, Services)], [End User (Biotechnology/Biopharmaceutical Company/ CROs, Academic and Research institute)]- Forecast to 2020
The purpose of this report is to cover the definition, description, and forecast of the Israel bio-pharma research market. It involves a deep dive analysis of the market segmentation, which is based on products & services and end-user. The report also gives deep insights into the competitive landscape of the market through a strategic analysis of the key players of the market. On the basis of products and services, the Israel bio-pharma research market is segmented into instruments, consumables, bioreactors, services, and software. The consumables market is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to the increasing usage of consumables along with automation and advancements in detection technologies. However, the software market is expected to witness the highest growth during the forecast period, owing to the advancements in bioinformatics tools.
Israel bio-pharma research market is subsegmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes on basis of end users. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to factors such as the technological advancements, increased investments from governments and private companies.
The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals of the major companies have been detailed in the report. The main companies operating in this market are Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson and Company (U.S.).
Israel bio-pharma research market is subsegmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes on basis of end users. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to factors such as the technological advancements, increased investments from governments and private companies.
The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals of the major companies have been detailed in the report. The main companies operating in this market are Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson and Company (U.S.).
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 KEY INDUSTRY INSIGHTS
2.2.3 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ISRAEL BIO-PHARMA RESEARCH MARKET TO GROW AT A STEADY RATE
4.2 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
4.3 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENTS AND CONSUMABLES
4.4 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENT
4.5 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET EVOLUTION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 RISING NUMBER OF PHARMACEUTICAL AND BIOTECH START-UPS
5.3.1.2 GOVERNMENT SUPPORT TO BOOST R&D ACTIVITIES
5.3.1.3 SUFFICIENT INVESTMENTS AND VENTURE CAPITAL FUNDS
5.3.1.4 AVAILABILITY OF SKILLED AND DIVERSE WORKFORCE
5.3.2 RESTRAINTS
5.3.3 OPPORTUNITIES
5.3.3.1 MERGERS & ACQUISITIONS
5.3.4 CURRENT TRENDS
5.3.4.1 ISRAELI BIOPHARMACEUTICAL COMPANIES INITIATING IPOS
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 MAJOR PRE-CLINICAL TRIALS OF BIOPHARMACEUTICAL PRODUCTS IN ISRAEL
6.3 ONGOING BIOPHARMACEUTICAL CLINICAL TRIALS IN ISRAEL
6.4 BUDGET/ PLANNED INVESTMENTS
7 ISRAEL HEALTHCARE SYSTEM
7.1 OVERVIEW
7.2 HISTORICAL DEVELOPMENT OF THE HEALTH SYSTEM IN ISRAEL
7.3 HEALTHCARE INDUSTRY IN ISRAEL
7.4 DISEASE BURDEN IN ISRAEL
7.5 HEALTHCARE EXPENDITURE IN ISRAEL
7.6 DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS
7.7 LEGAL REGULATORY FRAMEWORK OF CLINICAL TRIALS IN ISRAEL
7.7.1 LEGISLATION
7.7.2 REGULATORY AUTHORIZATION
7.7.3 DOCUMENTS REQUIRED
7.7.4 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE
7.8 ISRAEL: PHARMACEUTICAL IMPORT AND EXPORT
8 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
8.1 INTRODUCTION
8.2 CONSUMABLES
8.2.1 INTRODUCTION
8.2.2 ASSAYS KITS AND REAGENTS
8.2.3 CELL CULTURE MEDIA
8.2.4 CELL LINES
8.2.5 MICROPLATES
8.2.6 OTHER CONSUMABLES
8.3 INSTRUMENTS
8.3.1 SEPARATION INSTRUMENTS
8.3.2 DETECTION AND SCREENING EQUIPMENT
8.3.3 IMAGING INSTRUMENTS
8.3.4 AUTOMATION AND HIGH-THROUGHPUT SCREENING INSTRUMENTS
8.3.5 OTHER INSTRUMENTS
8.4 BIOREACTORS
8.4.1 STAINLESS STEEL BIOREACTORS
8.4.2 SINGLE-USE BIOREACTORS
8.5 SOFTWARE
8.6 SERVICES
9 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
9.1 INTRODUCTION
9.2 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS
9.3 ACADEMIC AND RESEARCH INSTITUTES
10 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 AGILENT TECHNOLOGIES
10.2 BIO-RAD LABORATORIES, INC.
10.3 THERMO FISHER SCIENTIFIC, INC.
10.4 MERCK KGAA
10.5 PERKINELMER, INC.
10.6 SIGMA-ALDRICH CORPORATION
10.7 WATERS CORPORATION
10.8 SARTORIUS AG
10.9 BECTON, DICKINSON AND COMPANY
10.10 GENE BIO-APPLICATION LTD.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 MARKET SHARE ANALYSIS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 KEY INDUSTRY INSIGHTS
2.2.3 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ISRAEL BIO-PHARMA RESEARCH MARKET TO GROW AT A STEADY RATE
4.2 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
4.3 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENTS AND CONSUMABLES
4.4 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENT
4.5 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET EVOLUTION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 RISING NUMBER OF PHARMACEUTICAL AND BIOTECH START-UPS
5.3.1.2 GOVERNMENT SUPPORT TO BOOST R&D ACTIVITIES
5.3.1.3 SUFFICIENT INVESTMENTS AND VENTURE CAPITAL FUNDS
5.3.1.4 AVAILABILITY OF SKILLED AND DIVERSE WORKFORCE
5.3.2 RESTRAINTS
5.3.3 OPPORTUNITIES
5.3.3.1 MERGERS & ACQUISITIONS
5.3.4 CURRENT TRENDS
5.3.4.1 ISRAELI BIOPHARMACEUTICAL COMPANIES INITIATING IPOS
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 MAJOR PRE-CLINICAL TRIALS OF BIOPHARMACEUTICAL PRODUCTS IN ISRAEL
6.3 ONGOING BIOPHARMACEUTICAL CLINICAL TRIALS IN ISRAEL
6.4 BUDGET/ PLANNED INVESTMENTS
7 ISRAEL HEALTHCARE SYSTEM
7.1 OVERVIEW
7.2 HISTORICAL DEVELOPMENT OF THE HEALTH SYSTEM IN ISRAEL
7.3 HEALTHCARE INDUSTRY IN ISRAEL
7.4 DISEASE BURDEN IN ISRAEL
7.5 HEALTHCARE EXPENDITURE IN ISRAEL
7.6 DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS
7.7 LEGAL REGULATORY FRAMEWORK OF CLINICAL TRIALS IN ISRAEL
7.7.1 LEGISLATION
7.7.2 REGULATORY AUTHORIZATION
7.7.3 DOCUMENTS REQUIRED
7.7.4 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE
7.8 ISRAEL: PHARMACEUTICAL IMPORT AND EXPORT
8 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
8.1 INTRODUCTION
8.2 CONSUMABLES
8.2.1 INTRODUCTION
8.2.2 ASSAYS KITS AND REAGENTS
8.2.3 CELL CULTURE MEDIA
8.2.4 CELL LINES
8.2.5 MICROPLATES
8.2.6 OTHER CONSUMABLES
8.3 INSTRUMENTS
8.3.1 SEPARATION INSTRUMENTS
8.3.2 DETECTION AND SCREENING EQUIPMENT
8.3.3 IMAGING INSTRUMENTS
8.3.4 AUTOMATION AND HIGH-THROUGHPUT SCREENING INSTRUMENTS
8.3.5 OTHER INSTRUMENTS
8.4 BIOREACTORS
8.4.1 STAINLESS STEEL BIOREACTORS
8.4.2 SINGLE-USE BIOREACTORS
8.5 SOFTWARE
8.6 SERVICES
9 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
9.1 INTRODUCTION
9.2 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS
9.3 ACADEMIC AND RESEARCH INSTITUTES
10 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 AGILENT TECHNOLOGIES
10.2 BIO-RAD LABORATORIES, INC.
10.3 THERMO FISHER SCIENTIFIC, INC.
10.4 MERCK KGAA
10.5 PERKINELMER, INC.
10.6 SIGMA-ALDRICH CORPORATION
10.7 WATERS CORPORATION
10.8 SARTORIUS AG
10.9 BECTON, DICKINSON AND COMPANY
10.10 GENE BIO-APPLICATION LTD.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 MARKET SHARE ANALYSIS
LIST OF TABLES
Table 1 RISING NUMBER OF PHARMACEUTICAL & BIOTECH START-UPS AND GOVERNMENT SUPPORT TO DRIVE THE ISRAEL BIO-PHARMA RESEARCH MARKET
Table 2 STRINGENT REGULATIONS FOR DRUG PRICING TO RESTRAIN THE ISRAEL BIO-PHARMA RESEARCH MARKET GROWTH
Table 3 MERGERS AND ACQUISITIONS ARE PROVIDING SIGNIFICANT GROWTH OPPORTUNITIES FOR THE ISRAEL BIO-PHARMA RESEARCH MARKET
Table 4 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014
Table 5 ISRAEL: TOP DISEASES WITH HIGH MORTALITY RATES, 2012
Table 6 ISRAEL: NATIONAL EXPENDITURE ON HEALTH, BY TYPE OF SERVICE, OPERATING SECTOR, AND TYPE OF EXPENDITURE, 2012
Table 7 SUBMISSION PACKAGE REQUIRED FOR APPROVAL OF A CLINICAL STUDY IN ISRAEL
Table 8 ISRAEL: TOP IMPORTS, 2014
Table 9 ISRAEL: TOP EXPORTS, 2014
Table 10 LIST OF 17 MAJOR COMPANIES IN ISRAEL EXPORTING MEDICINE TO THE U.S., 2012
Table 11 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION)
Table 12 ISRAEL BIO-PHARMA RESEARCH CONSUMABLES MARKET SIZE, BY TYPE, 2013-–2020 (USD MILLION)
Table 13 ISRAEL BIO-PHARMA RESEARCH INSTRUMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
Table 14 ISRAEL BIO-PHARMA RESEARCH BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
Table 15 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 1 RISING NUMBER OF PHARMACEUTICAL & BIOTECH START-UPS AND GOVERNMENT SUPPORT TO DRIVE THE ISRAEL BIO-PHARMA RESEARCH MARKET
Table 2 STRINGENT REGULATIONS FOR DRUG PRICING TO RESTRAIN THE ISRAEL BIO-PHARMA RESEARCH MARKET GROWTH
Table 3 MERGERS AND ACQUISITIONS ARE PROVIDING SIGNIFICANT GROWTH OPPORTUNITIES FOR THE ISRAEL BIO-PHARMA RESEARCH MARKET
Table 4 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014
Table 5 ISRAEL: TOP DISEASES WITH HIGH MORTALITY RATES, 2012
Table 6 ISRAEL: NATIONAL EXPENDITURE ON HEALTH, BY TYPE OF SERVICE, OPERATING SECTOR, AND TYPE OF EXPENDITURE, 2012
Table 7 SUBMISSION PACKAGE REQUIRED FOR APPROVAL OF A CLINICAL STUDY IN ISRAEL
Table 8 ISRAEL: TOP IMPORTS, 2014
Table 9 ISRAEL: TOP EXPORTS, 2014
Table 10 LIST OF 17 MAJOR COMPANIES IN ISRAEL EXPORTING MEDICINE TO THE U.S., 2012
Table 11 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION)
Table 12 ISRAEL BIO-PHARMA RESEARCH CONSUMABLES MARKET SIZE, BY TYPE, 2013-–2020 (USD MILLION)
Table 13 ISRAEL BIO-PHARMA RESEARCH INSTRUMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
Table 14 ISRAEL BIO-PHARMA RESEARCH BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
Table 15 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION
Figure 3 BREAK DOWN OF PRIMARY INTERVIEWS
Figure 4 MARKET DATA TRIANGULATION METHODOLOGY
Figure 5 ISRAEL BIO-PHARMA RESEARCH MARKET SNAPSHOT (2015 VS. 2020)
Figure 6 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS AND SERVICES, 2015
Figure 7 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT WILL CONTINUE TO LEAD THE MARKET DURING THE FORECAST PERIOD
Figure 8 RISING NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY START-UPS AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH
Figure 9 SOFTWARE SEGMENT WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
Figure 10 CONSUMABLES SEGMENT TO DOMINATE THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015
Figure 11 IMAGING INSTRUMENTS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ISRAEL BIO-PHARMA RESEARCH IN 2015
Figure 12 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020
Figure 13 EVOLUTION OF THE BIOPHARMACEUTICAL R&D SECTOR IN ISRAEL
Figure 14 ISRAEL BIO-PHARMA RESEARCH MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES
Figure 15 ISRAEL: VENTURE CAPITAL FUNDING, LOCAL VS. FOREIGN, 2004–2013
Figure 16 DEVELOPMENTAL STAGES OF BIOPHARMACEUTICAL COMPANIES, 2014
Figure 17 CLINICAL TRIAL STAGE OF BIOPHARMACEUTICAL PRODUCTS IN 2015
Figure 18 CAPITAL RAISED BY ISRAELI LIFE SCIENCES COMPANIES, 2005-2017 (USD MILLION)
Figure 19 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014
Figure 20 ISRAEL: DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS
Figure 21 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE
Figure 22 ISRAEL: PHARMACEUTICAL IMPORTS ACCOUNTED FOR 2.6% OF THE TOTAL IMPORTS IN THE COUNTRY IN 2014
Figure 23 ISRAEL: PHARMACEUTICAL EXPORTS ACCOUNTED FOR 9.0% OF TOTAL EXPORTS BY THE COUNTRY
Figure 24 CONSUMABLES TO FORM THE LARGEST SEGMENT OF THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015
Figure 25 ASSAYS KITS AND REAGENTS IS EXPECTED TO DOMINATE THE CONSUMABLES MARKET IN 2015
Figure 26 IMAGING INSTRUMENTS TO COMMAND LARGEST SHARE OF THE ISRAEL BIO-PHARMA RESEARCH INSTRUMENTS MARKET IN 2015
Figure 27 SINGLE-USE BIOREACTORS IS EXPECTED TO BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
Figure 28 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS, THE MAJOR END USERS OF THE ISRAEL BIO-PHARMA RESEARCH MARKET
Figure 29 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
Figure 30 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
Figure 31 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Figure 33 MERCK KGAA: COMPANY SNAPSHOT
Figure 34 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 35 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
Figure 36 WATERS CORPORATION: COMPANY SNAPSHOT
Figure 37 SARTORIUS AG: COMPANY SNAPSHOT
Figure 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 39 ISRAEL BIO-PHARMA RESEARCH MARKET SHARE, BY KEY PLAYER, 2014
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION
Figure 3 BREAK DOWN OF PRIMARY INTERVIEWS
Figure 4 MARKET DATA TRIANGULATION METHODOLOGY
Figure 5 ISRAEL BIO-PHARMA RESEARCH MARKET SNAPSHOT (2015 VS. 2020)
Figure 6 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS AND SERVICES, 2015
Figure 7 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT WILL CONTINUE TO LEAD THE MARKET DURING THE FORECAST PERIOD
Figure 8 RISING NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY START-UPS AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH
Figure 9 SOFTWARE SEGMENT WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
Figure 10 CONSUMABLES SEGMENT TO DOMINATE THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015
Figure 11 IMAGING INSTRUMENTS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ISRAEL BIO-PHARMA RESEARCH IN 2015
Figure 12 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS SEGMENT TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020
Figure 13 EVOLUTION OF THE BIOPHARMACEUTICAL R&D SECTOR IN ISRAEL
Figure 14 ISRAEL BIO-PHARMA RESEARCH MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES
Figure 15 ISRAEL: VENTURE CAPITAL FUNDING, LOCAL VS. FOREIGN, 2004–2013
Figure 16 DEVELOPMENTAL STAGES OF BIOPHARMACEUTICAL COMPANIES, 2014
Figure 17 CLINICAL TRIAL STAGE OF BIOPHARMACEUTICAL PRODUCTS IN 2015
Figure 18 CAPITAL RAISED BY ISRAELI LIFE SCIENCES COMPANIES, 2005-2017 (USD MILLION)
Figure 19 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014
Figure 20 ISRAEL: DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS
Figure 21 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE
Figure 22 ISRAEL: PHARMACEUTICAL IMPORTS ACCOUNTED FOR 2.6% OF THE TOTAL IMPORTS IN THE COUNTRY IN 2014
Figure 23 ISRAEL: PHARMACEUTICAL EXPORTS ACCOUNTED FOR 9.0% OF TOTAL EXPORTS BY THE COUNTRY
Figure 24 CONSUMABLES TO FORM THE LARGEST SEGMENT OF THE ISRAEL BIO-PHARMA RESEARCH MARKET IN 2015
Figure 25 ASSAYS KITS AND REAGENTS IS EXPECTED TO DOMINATE THE CONSUMABLES MARKET IN 2015
Figure 26 IMAGING INSTRUMENTS TO COMMAND LARGEST SHARE OF THE ISRAEL BIO-PHARMA RESEARCH INSTRUMENTS MARKET IN 2015
Figure 27 SINGLE-USE BIOREACTORS IS EXPECTED TO BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
Figure 28 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS, THE MAJOR END USERS OF THE ISRAEL BIO-PHARMA RESEARCH MARKET
Figure 29 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
Figure 30 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
Figure 31 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Figure 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Figure 33 MERCK KGAA: COMPANY SNAPSHOT
Figure 34 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 35 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
Figure 36 WATERS CORPORATION: COMPANY SNAPSHOT
Figure 37 SARTORIUS AG: COMPANY SNAPSHOT
Figure 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 39 ISRAEL BIO-PHARMA RESEARCH MARKET SHARE, BY KEY PLAYER, 2014
